Age-Related Macular Degeneration: Clinical Findings following Treatment with Antiangiogenic Drugs

Table 2

Description of the lesion and symptoms at diagnosis.

Variable	Study eye—𝑛 (%)
Lesion type
Total	208 (100%)
Classic	83 (39.9%)
Minimally classic	23 (11.1%)
Occult	71 (34.1%)
Other shapes	12 (5.8%)
RAP	9 (4.3%)
IPCV	3 (1.4%)
Unknown	19 (9.1%)
Lesion size
Total	208 (100%)
<1 disk	38 (18.3%)
1-2 disks	90 (43.3%)
>2 disks	42 (20.2%)
Unknown	38 (18.3%)
Subretinal neovascular membrane location
Total	208 (100%)
Yuxtapapillar	3 (1.4%)
Extrafoveal	22 (10.6%)
Yuxtafoveal	78 (37.5%)
Subfoveal	104 (50.0%)
Subfoveal + Yuxtapapillar	1 (0.5%)
Presence of symptoms at diagnosis
Total	208 (100%)
Yes	208 (100%)
Symptoms at diagnosis
Sudden and progressive loss of VA	136 (65.4%)
Central scotoma	88 (42.3%)
Difficulty to read	49 (23.6%)
Metamorphopsia	99 (47.6%)
Photopsia	1 (0.5%)
Other symptoms	2 (1.0%)
Other symptoms
Total	2 (100%)

RAP: retinal angiomatous proliferation; IPCV: idiopathic polypoidal choroidal vasculopathy; VA: visual acuity.